As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Cancer/Tumour Profiling Market: By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Others; By Biomarker Type; By Technology; By Application; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Cancer/Tumour Profiling Market Outlook

The global cancer/tumour profiling market attained a value of USD around 7.8 billion in 2020. The cancer/tumour profiling market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 10.2% to reach USD 14 billion by 2026.

 

Global Cancer/Tumour Profiling Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The rising rate of cancer globally and the growing use of biomarkers in the production of tumours are the main drivers for the growth of the cancer/tumour profiling market.

 

Properties and Applications

Cancer is a life-threatening illness that is characterised by uncontrolled cell growth. This is mainly due to environmental reasons which alter the gene encoding that regulates cells. The resulting cell mutation results in abnormal cell growth, killing the surrounding normal tissue and then spreading it to very important organs. Cancer/tumour profiling is done to gain insight into a patient's cancer profile and genomic adjustments that enable physicians to guide a patient to the most appropriate treatment. Therefore, profiling also allows doctors to avoid interventions that are questionable and, thus, reduce mistakes and trial procedures.

 

Global Cancer/Tumour Profiling Market By Technology

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The types of cancer can be divided into:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Melanoma
  • Others

The types of biosensors can be segmented into:

  • Genetic Biomarkers
  • Protein Biomarkers
  • Others

The cancer/tumour profiling market can be broadly categorised based on technology into:

  • Immunoassays 
  • Next-Generation Sequencing 
  • Polymerase Chain Reaction 
  • In Situ Hybridization
  • Microarrays 
  • Mass Spectrometry
  • Others

It finds its uses in the research and clinical applications.

Research applications can be further divided into:

  • Biomarker Discovery
  • Personalized Medicine

Clinical applications are further categorised into:

  • Diagnostics
  • Prognostics
  • Monitoring and Treatment
  • Screening

The EMR report looks into the regional markets of cancer/tumour profiling like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Cancer/Tumour Profiling Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

A significant growth in the global market for cancer/tumour profiling is expected in the coming years, mainly owing to the increased funding of activities to improve the overall course of the diagnosis and treatment of the disease and the recent comprehensive technological advancements in the area of tumour profiling. The market is also being driven by the growing use of medical diagnostics and the resulting increase in the demand for personalized medicinal products.

The constantly increasing socio-economic burden of cancer and the demand from the health industry to establish effective methods of treating and controlling it also drives the market for the profiling of cancer/tumours. Nonetheless, the additional expenditure needed by profiling procedures may in some way impede its adoption, limiting the scope of these processes to high-income regions. Nonetheless, through government intervention and support from the public and private institutions for cancer diagnosis and treatment are expected to allow the market to achieve promising avenues for development.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global cancer/tumour profiling market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Illumina, Inc. (NASDAQ: ILMN)
  • Qiagen N.V. 
  • Neogenomic Laboratories, Inc. 
  • Sysmex Corporation 
  • HTG Molecular Diagnostics, Inc. 
  • Helomics Corporation 
  • Genomic Health, Inc. 
  • Caris Life Sciences
  • Others

The EMR report gives an in-depth insight into the cancer/tumour profiling market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Questions Answered in the Market Report

  • How has the global cancer/tumour profiling market performed in the previous years (2016-2020)?
  • What is the forecast assessment of the cancer/tumour profiling market for 2021-2026?
  • What are the major drivers of the historical (2016-2020) and forecast (2021-2026) periods?
  • What are the major constraints of the historical (2016-2020) and forecast (2021-2026) periods?
  • What are the major demand indicators of the global cancer/tumour profiling market?
  • Who are the key players in the global cancer/tumour profiling market?
  • What is the degree of competition in the global cancer/tumour profiling market?
  • What are the major events and developments taking place within the global cancer/tumour profiling industry?

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Cost Structure
    4.5    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraint Analysis
    5.3    Industry Challenges
    5.4    Industry Opportunities
6     Global Cancer/Tumour Profiling Market Analysis
    6.1    Figure: Global Cancer/Tumour Profiling Historical Market (2016-2020) & Forecast (2021-2026)
    6.2    Chart: Global Cancer/Tumour or Profiling Market Breakup by Cancer Type
        6.2.1    Breast Cancer 
        6.2.2    Lung Cancer 
        6.2.3    Colorectal Cancer 
        6.2.4    Prostate Cancer 
        6.2.5    Melanoma 
        6.2.6    Others
    6.3    Figure: Global Cancer/Tumour Profiling Market Breakup by Cancer Type: Historical Market (2016-2020) & Forecast (2021-2026)
        6.3.1    Breast Cancer 
        6.3.2    Lung Cancer 
        6.3.3    Colorectal Cancer 
        6.3.4    Prostate Cancer 
        6.3.5    Melanoma 
        6.3.6    Others
    6.4    Chart: Global Cancer/Tumour Profiling Market Breakup by Biomarker Type
        6.4.1    Genetic Biomarkers 
        6.4.2    Protein Biomarkers 
        6.4.3    Others
    6.5    Figure: Global Cancer/Tumour Profiling Market Breakup by Biomarker Type: Historical Market (2016-2020) & Forecast (2021-2026)
        6.5.1    Genetic Biomarkers
        6.5.2    Protein Biomarkers
        6.5.3    Others
    6.6    Chart: Global Cancer/Tumour Profiling Market Breakup by Technology
        6.6.1    Immunoassays 
        6.6.2    Next-Generation Sequencing 
        6.6.3    Polymerase Chain Reaction 
        6.6.4    In Situ Hybridization
        6.6.5    Microarrays 
        6.6.6    Mass Spectrometry
        6.6.7    Others 
    6.7    Figure: Global Cancer/Tumour Profiling Market Breakup by Technology: Historical Market (2016-2020) & Forecast (2021-2026)
        6.7.1    Immunoassays 
        6.7.2    Next-Generation Sequencing 
        6.7.3    Polymerase Chain Reaction 
        6.7.4    In Situ Hybridization
        6.7.5    Microarrays 
        6.7.6    Mass Spectrometry
        6.7.7    Others 
    6.8    Chart: Global Cancer/Tumour Profiling Market by Application
        6.8.1    Research Applications 
            6.8.1.1    Biomarker Discovery
            6.8.1.2    Personalized Medicine
        6.8.2    Clinical Applications 
            6.8.2.1    Diagnostics
            6.8.2.2    Prognostics
            6.8.2.3    Monitoring and Treatment
            6.8.2.4    Screening
    6.9    Figure: Global Cancer/Tumour Profiling Market by Application: Historical Market (2016-2020) & Forecast (2021-2026)
        6.9.1    Research Applications 
            6.9.1.1    Biomarker Discovery
            6.9.1.2    Personalized Medicine
        6.9.2    Clinical Applications 
            6.9.2.1    Diagnostics
            6.9.2.2    Prognostics
            6.9.2.3    Monitoring and Treatment
            6.9.2.4    Screening
    6.10     Chart: Global Cancer/Tumour Profiling Market Breakup by Region
        6.10.1    North America
            6.10.1.1    United States of America
            6.10.1.2    Canada
        6.10.2    Europe
            6.10.2.1    United Kingdom
            6.10.2.2    Germany
            6.10.2.3    France
            6.10.2.4    Italy
            6.10.2.5    Others
        6.10.3    Asia Pacific
            6.10.3.1    China
            6.10.3.2    India
            6.10.3.3    Japan
            6.10.3.4    ASEAN
            6.10.3.5    Others
        6.10.4    Latin America
            6.10.4.1    Brazil
            6.10.4.2    Argentina
            6.10.4.3    Mexico
            6.10.4.4    Others
        6.10.5    Middle East & Africa
            6.10.5.1    Saudi Arabia
            6.10.5.2    United Arab Emirates
            6.10.5.3    Nigeria
            6.10.5.4    South Africa
            6.10.5.5    Others
    6.11    Figure: Global Cancer/Tumour Profiling Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        6.11.1    North America
            6.11.1.1    United States of America
            6.11.1.2    Canada
        6.11.2    Europe
            6.11.2.1    United Kingdom
            6.11.2.2    Germany
            6.11.2.3    France
            6.11.2.4    Italy
            6.11.2.5    Others
        6.11.3    Asia Pacific
            6.11.3.1    China
            6.11.3.2    India
            6.11.3.3    Japan
            6.11.3.4    ASEAN
            6.11.3.5    Others
        6.11.4    Latin America
            6.11.4.1    Brazil
            6.11.4.2    Argentina
            6.11.4.3    Mexico
            6.11.4.4    Others
        6.11.5    Middle East & Africa
            6.11.5.1    Saudi Arabia
            6.11.5.2    United Arab Emirates
            6.11.5.3    Nigeria
            6.11.5.4    South Africa
            6.11.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    EMR’s Key Indicators for Demand
10    Competitive Landscape & Supplier Analysis

    10.1    Illumina, Inc. (NASDAQ: ILMN)
        10.1.1    Company Overview
        10.1.2    Financial Analysis
    10.2    Qiagen N.V. (NYSE: QGEN)
        10.2.1    Company Overview
        10.2.2    Financial Analysis 
    10.3    Neogenomic Laboratories, Inc. (NASDAQ: NEO)
        10.3.1    Company Overview
        10.3.2    Financial Analysis
    10.4    Sysmex Corporation (TYO: 6869)
        10.4.1    Company Overview
        10.4.2    Financial Analysis
    10.5    HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM)
        10.5.1    Company Overview
        10.5.2    Financial Analysis
    10.6    Helomics Corporation 
        10.6.1    Company Overview
        10.6.2    Financial Analysis
    10.7    Genomic Health, Inc. 
        10.7.1    Company Overview
        10.7.2    Financial Analysis
    10.8    Caris Life Sciences
        10.8.1    Company Overview
        10.8.2    Financial Analysis
    10.9    Others
11    Industry Events and Developments

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Cancer Screening Market Report and Forecast 2021-2026


Global Testosterone Test Kits Market Report and Forecast 2021-2026


Global Glycated Haemoglobin Testing Market Report and Forecast 2021-2026


Global Lipase Testing Market Report and Forecast 2021-2026


Global Wellness Genomics Market Report and Forecast 2021-2026


NEWSLETTER